These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 928256)
1. Information centres in the pharmaceutical industry--the prime source of drug information. Kenny EC Postgrad Med J; 1977 Sep; 53(623):562-5. PubMed ID: 928256 [TBL] [Abstract][Full Text] [Related]
2. Hospital pharmacy information centres and their role as suppliers of information. McNulty H Postgrad Med J; 1977 Sep; 53(623):556-8. PubMed ID: 928254 [TBL] [Abstract][Full Text] [Related]
3. Identifying the medical consultants of pharmaceutical companies. Burley DM Lancet; 1979 Aug; 2(8138):354. PubMed ID: 89407 [No Abstract] [Full Text] [Related]
4. A case of indomethacin toxicity: the drug information network and its benefits in therapy. Bainbridge CV; Ruger JR Drug Inf J; 1979; 13(1):35-40. PubMed ID: 10242951 [No Abstract] [Full Text] [Related]
5. Being a modern pharmaceutical company: involves making information available on clinical trial programmes. Sykes R BMJ; 1998 Oct; 317(7167):1172. PubMed ID: 9794848 [No Abstract] [Full Text] [Related]
6. Aspects of medical communications in the United Kingdom. Higgins DG Drug Inf J; 1975; 9(1):32-7. PubMed ID: 10236955 [No Abstract] [Full Text] [Related]
7. [Organization of drug information work in a pharmaceutical information center]. Nikitina NI Farm Zh; 1979; (2):10-2. PubMed ID: 456502 [No Abstract] [Full Text] [Related]
9. Representatives and advertisements as sources of information. Holland AE Postgrad Med J; 1977 Sep; 53(623):559-61. PubMed ID: 928255 [TBL] [Abstract][Full Text] [Related]
10. [Work experience of a pharmaceutical information office]. Visiahina LH; Semeniuk VV Farm Zh; 1979; (2):13-4. PubMed ID: 456503 [No Abstract] [Full Text] [Related]
11. Drug information centres: an industry view. Buckland P Proc R Soc Med; 1977 Apr; 70(4):253-5. PubMed ID: 866327 [No Abstract] [Full Text] [Related]
12. Interactions between physicians and the pharmaceutical industry: what does the literature say? Lexchin J CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424 [TBL] [Abstract][Full Text] [Related]
13. The function of drug company representatives. Hemminki E; Pesonen T Scand J Soc Med; 1977; 5(3):105-14. PubMed ID: 594704 [TBL] [Abstract][Full Text] [Related]
14. Drug information: the pharmaceutical manufacturer's viewpoint and involvement. Meadows RJ Drug Inf J; 1977; 11(4):221-4. PubMed ID: 10307453 [No Abstract] [Full Text] [Related]
15. The medical copywriter in the pharmaceutical industry: an uphill climb after a downhill slide. Stahl E Drug Inf J; 1977; 11(4):215-7. PubMed ID: 10307452 [No Abstract] [Full Text] [Related]
16. [Creation of an integral system of scientific pharmaceutical information]. ParnovskiÄ BL Farmatsiia; 1979; 28(5):6-10. PubMed ID: 488404 [No Abstract] [Full Text] [Related]
17. A drug information system provided by a transnational pharmaceutical firm for use by the practicing physician. Dittmer I Drug Inf J; 1975; 9(1):27-9. PubMed ID: 10236953 [No Abstract] [Full Text] [Related]
18. Identifying the medical consultants of pharmaceutical companies. Dukes MN Lancet; 1979 Sep; 2(8144):696. PubMed ID: 90786 [No Abstract] [Full Text] [Related]
19. A survey of funding sources of drug information centers in the United States. Hambley CD; Pevonka MP; Stewart RB Drug Inf J; 1979; 13(1):54-6. PubMed ID: 10242954 [No Abstract] [Full Text] [Related]
20. Drug information services at Eli Lilly and Company. Pfeil-Doyle JL; Jones MD; Oberlin JA; Benitez J Am J Hosp Pharm; 1990 Sep; 47(9):1996-8. PubMed ID: 2220850 [No Abstract] [Full Text] [Related] [Next] [New Search]